1. Home
  2. Analysis
  3. Oramorph-sr
  4. Aggrenox

Oramorph sr and Aggrenox drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Oramorph sr (morphine sulfate) and Aggrenox (aspirin; dipyridamole). Common drug interactions include constipation among females.

The phase IV clinical study analyzes what interactions people have when they take Oramorph sr and Aggrenox. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Oramorph sr?

Oramorph sr has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 2,897 Oramorph sr users. Check the latest studies of Oramorph sr.

What is Aggrenox?

Aggrenox has active ingredients of aspirin; dipyridamole. It is often used in stroke. eHealthMe is studying from 7,654 Aggrenox users. Check the latest studies of Aggrenox.

On Jul, 30, 2026

35 people who take Oramorph sr and Aggrenox together, and have interactions are studied.

Oramorph sr and Aggrenox drug interactions.

What are the common drug interactions of Oramorph Sr and Aggrenox, by gender? *:

female:

  1. Constipation
  2. Balance disorder
  3. Sedation
  4. Overdose
  5. Dyspnoea (difficult or laboured respiration)
  6. Creatinine renal clearance increased
  7. Drug abuse
  8. Blood calcium decreased
  9. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  10. Creatinine renal clearance decreased

male:

n/a

What are the common drug interactions of Oramorph Sr and Aggrenox, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Constipation
  2. Balance disorder
  3. Sedation
  4. Overdose
  5. Dyspnoea (difficult or laboured respiration)
  6. Creatinine renal clearance increased
  7. Drug abuse
  8. Blood calcium decreased
  9. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  10. Creatinine renal clearance decreased

What are the existing conditions these people have? *

  1. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 35 people, 100.00%
  2. High Blood Pressure: 35 people, 100.00%
  3. Gastric Ulcer (stomach ulcer): 35 people, 100.00%
  4. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 34 people, 97.14%
  5. Stable Angina (a constant chest pain): 34 people, 97.14%
  6. Chest Pain: 34 people, 97.14%
  7. Oedema (fluid collection in tissue): 34 people, 97.14%
  8. Fibromyalgia (a long-term condition which causes pain all over the body): 34 people, 97.14%
  9. Constipation: 34 people, 97.14%
  10. Urinary Tract Infection: 28 people, 80.00%

* Approximation only. Some reports may have incomplete information.

Do you take Oramorph sr and Aggrenox?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Oramorph sr and Aggrenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Oramorph sr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Aggrenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oramorph sr and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aggrenox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate and aspirin; dipyridamole (the active ingredients of Oramorph sr and Aggrenox, respectively), and Oramorph sr and Aggrenox (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.